Cytodyn, Inc.

This study tested an experimental drug called PRO 140 in 6 adults with HIV whose current medications were no longer controlling the virus. The goal was to see if adding PRO 140 could lower the amount of HIV in their blood. The trial lasted 25 weeks and combined PRO 140 with other…

This study tested whether a weekly injection of PRO 140 could keep HIV under control in people whose virus was already suppressed by standard daily pills. 562 adults with a specific type of HIV (CCR5-tropic) switched from their usual combination therapy to PRO 140 alone for 48 we…

This study tested a drug called leronlimab in 484 hospitalized adults with severe or critical COVID-19. Participants received weekly injections of either leronlimab or a placebo. The main goal was to see if the drug could reduce deaths by day 28 and improve recovery.

This study tested a drug called leronlimab in 16 adults with advanced solid tumors that have a specific protein (CCR5+). The main goals were to check safety and see if the drug could slow tumor growth. Participants had already tried other treatments or had no standard options lef…